Tech Company Financing Transactions

Viamet Pharmaceuticals Funding Round

On 6/7/2007, Viamet Pharmaceuticals raised $4 million in Series A funding from Hatteras Venture Partners and Intersouth Partners.

Transaction Overview

Company Name
Viamet Pharmaceuticals
Announced On
6/7/2007
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Series A
Investors

Hatteras Venture Partners (Lead Investor) (Douglas Reed)

Intersouth Partners (Lead Investor) (Garheng Kong)

Proceeds Purpose
"This Series A financing will support the rapid development of our metalloenzyme inhibitor programs," said Robert Schotzinger, M.D., Ph.D., President and CEO of Viamet Pharmaceuticals.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4505 Emperor Blvd. 300
Durham, NC 27703
USA
Phone
(919) 467-8539
Website
www.viamet.com
Email Address
Not Recorded
Overview
Viamet Pharmaceuticals discovers and develops best-in-class inhibitors of validated metalloenzymes via an innovative and proprietary metal-binding approach, our Metallophile Technology.
Profile
Viamet Pharmaceuticals LinkedIn Company Profile
Social Media
Viamet Pharmaceuticals Company Twitter Account
Company News
Viamet Pharmaceuticals News
Facebook
Viamet Pharmaceuticals on Facebook
YouTube
Viamet Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Schotzinger
  Robert Schotzinger LinkedIn Profile  Robert Schotzinger Twitter Account  Robert Schotzinger News  Robert Schotzinger on Facebook
Chief Medical Officer
Oren Cohen
  Oren Cohen LinkedIn Profile  Oren Cohen Twitter Account  Oren Cohen News  Oren Cohen on Facebook
VP - Product Management
Thorsten Degenhardt
  Thorsten Degenhardt LinkedIn Profile  Thorsten Degenhardt Twitter Account  Thorsten Degenhardt News  Thorsten Degenhardt on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/6/2007: Aileron Therapeutics venture capital transaction
Next: 6/7/2007: OnePIN venture capital transaction

 

Share this article

 

About Our VC Transactions Data

Our team works diligently to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.